96 reports of this reaction
1.8% of all CEVIMELINE HYDROCHLORIDE reports
#11 most reported adverse reaction
MALAISE is the #11 most commonly reported adverse reaction for CEVIMELINE HYDROCHLORIDE, manufactured by Aurobindo Pharma Limited. There are 96 FDA adverse event reports linking CEVIMELINE HYDROCHLORIDE to MALAISE. This represents approximately 1.8% of all 5,260 adverse event reports for this drug.
Patients taking CEVIMELINE HYDROCHLORIDE who experience malaise should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MALAISE is a less commonly reported adverse event for CEVIMELINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to malaise, the following adverse reactions have been reported for CEVIMELINE HYDROCHLORIDE:
The following drugs have also been linked to malaise in FDA adverse event reports:
MALAISE has been reported as an adverse event in 96 FDA reports for CEVIMELINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
MALAISE accounts for approximately 1.8% of all adverse event reports for CEVIMELINE HYDROCHLORIDE, making it a notable side effect.
If you experience malaise while taking CEVIMELINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.